Bronchoscopic interventions for bronchopleural fistulas
Therapeutic Advances in Respiratory Disease · 2023
DOI: 10.1177/17534666231164541 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2023. Verfasst von Lingli Jin und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Pleural Diseases, Bronchial Fistula, Pneumonia. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Research and Development Project of Hainan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Bronchopleural fistula is a potentially fatal disease most often caused after pneumonectomy. Concomitant problems such as pulmonary infection and respiratory failure are typically the main contributors to patient mortality because of the improper contact between the bronchial and pleural cavity. Therefore, bronchopleural fistulas need immediate treatment, which requires the accurate location and timely closure of the fistula. Currently, bronchoscopic interventions, because of their flexibility and versatility, are reliable alternative therapies in patients for whom surgical intervention is unsuitable. Possible interventions include bronchoscopic placement of blocking agents, atrial septal defect (ASD)/ventricular septal defect (VSD) occluders, airway stents, endobronchial valves (EBVs) and endobronchial Watanabe spigots (EWSs). Recent developments in mesenchymal stem cells (MSCs) transplantation technology and three-dimensional (3D) printed stents have also contributed to the treatment of bronchopleural fistula, but more research is needed to investigate the long-term benefits. This review focuses on the effectiveness of various bronchoscopic measures for the treatment of bronchopleural fistula and the directions for future development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Internal Medicine, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
- Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, China.
- Department of Internal Medicine, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China.
- Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou 310022, China.
- Department of Pulmonary and Critical Care Medicine, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou 570100, China.
ORCID-Profile: Lingli Jin
Förderung
- Key Research and Development Project of Hainan Province
- National Natural Science Foundation of China
Zitieren
APA
Jin, L., & Li, Y. (2023). Bronchoscopic interventions for bronchopleural fistulas. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666231164541
Vancouver
Jin L, Li Y. Bronchoscopic interventions for bronchopleural fistulas. Therapeutic Advances in Respiratory Disease. 2023. doi:10.1177/17534666231164541
BibTeX
@article{Jin2023,
author = {Jin, Lingli and Li, Yaqing},
title = {Bronchoscopic interventions for bronchopleural fistulas},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2023},
doi = {10.1177/17534666231164541}
}
EUVIMED